Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Conference Posters and Presentations
2022 AALAS P31 Practicing the 3R's

2022 AALAS P31 Practicing the 3R's

Published Date October 24, 2022

Previous Flipbook

2022 AALAS P231 Initial Validation and Ongoing Quality Control of Process Equipment
Next Flipbook

2022 AALAS P52 How the IACUC Worked with Business Partners to Develop a Safety Review Process to Reduce Regulatory Burden

Most Recent Flipbooks

6 months ago
2023 AACR The use of PBMC humanized mice to test the efficacy and safety of antibody and cell-based cancer immunotherapeutics

Read Flipbook
6 months ago
2023 AACR Novel preclinical model for the evaluation of cytokine release syndrome in response to CD19xCD3 bispecific antibody in humanized m

Read Flipbook
6 months ago
2023 AACR A new tumor-bearing humanized mouse model to evaluate the efficacy of bispecific T cell engager and monoclonal checkpoint antibodi

Read Flipbook
6 months ago
2023 AACR Comparisons of Rituximab and CD19xCD3 BiTE antitumor response across multiple humanized NSG strains engrafted with human hematopoi

Read Flipbook
6 months ago
2023 AACR Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunother

Read Flipbook
6 months ago
2023 AACR Mouse models of cancer available from The Jackson Laboratory

Read Flipbook
9 months ago
2022 ASH Poster: In Vivo PBMC Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicology

Read Flipbook
10 months ago
2022 SfN Poster: 374.18 Exploring SARM1 Inhibition in Mouse Models of CMT (1)

Read Flipbook
10 months ago
2022 PEGS EU Immune System-Humanized Mouse Models to Predict Outcomes of Human-Specific Immuno-Modulatory Therapies

Read Flipbook
10 months ago
2022 PEGS EU A Translational Model for Drug-Induced Cytokine Release Syndrome-Associated Systemic Toxicity in the Humanized Mouse

Read Flipbook
10 months ago
2022 PEGS EU In vivo Evaluation of the Effects of Fc-Silencing Mutations on Antibody Half-Life Using FcRn Humanized Mouse Models

Read Flipbook
10 months ago
2022 SfN 613-Virtual Genetically Diverse Mouse Models of Alzheimer’s Disease Reveal an Association Between Glycan Metabolism and Cerebral Am

Read Flipbook
10 months ago
2022 SfN 613.20 Transcriptional Assessment of Novel Mouse Models Harboring Human Genetic Variants Associated With Late-Onset Alzheimer’s Dis

Read Flipbook
10 months ago
2022 SfN 624.13 Targeting the Immune Contributions to Neurodegeneration Via the Il1rap Signaling Axis

Read Flipbook
10 months ago
2022 SfN 374.05 Towards In Vivo Studies of C12ORF65MTRFR Deficiency in Mitochondrial Translation in Neurons

Read Flipbook
10 months ago
2022 SfN 283.08 Cerebral Organoids Reveal Genetic Differences Associated With Resilience in an In Vitro Stroke Model

Read Flipbook
10 months ago
2022 SfN 370.12 Characterization of Aging X Genetic X Environment as Precision Disease Models For Evaluation of Therapeutic Interventions Fo

Read Flipbook
10 months ago
2022 SfN 374.14 Sipa1l2, a Candidate Modifier of CMT1A from Human GWAS, Does Not Alter Neuromuscular Phenotypes in C3-PMP22 Mice When Delete

Read Flipbook
10 months ago
2022 SfN 374.01 Preclinical Studies Inhibiting GCN2 and the Integrated Stress Response in Mouse Models of CMT2D

Read Flipbook
10 months ago
2022 SfN 85.11 Methodology to Objectively Prioritize Therapeutic Hypotheses in Alzheimer’s Disease Via Target Risk Scoring and Biological Do

Read Flipbook

Recommended for you

Return to Home

© The Jackson Laboratory